Robert I. Blum
Muna Bhanji has served as a member of our Board of Directors since February 2021. Her prior experience includes a 30+ year tenure at Merck, during which she held a number of senior leadership roles within the US and Global commercial organizations driving growth across a broad portfolio of medicines and vaccines of over $40+ billion annually. Most recently, through December 2020, she served as the Senior Vice President, Global Market Access & Policy with responsibility for enabling payer reimbursement and access for patients, for Merck’s products around the world. Muna Bhanji is the Founder and President, TIBA Global Access, a commercialization and market access strategy consultancy serving the biopharmaceutical industry. She currently serves on the board of directors of Corus International, an ensemble of faith-based organizations working at the intersection of poverty alleviation and healthcare, in the most underserved parts of the world. She has also served on the board of directors of Possible Health, a Nepal based NGO, providing integrated, high quality high, affordable healthcare to rural communities. Prior board of director service includes serving on the board of directors of the Foundation of Managed Care Pharmacy and chairing Merck’s Supervisory Board in the Netherlands. Muna earned her Bachelor of Pharmacy degree from Rutgers School of Pharmacy and an MBA from St. Joseph’s University.